These observations were verified via western blotting and quantitative polymerase chain reaction (qPCR) analyses of clinical samples, which revealed significantly lower expression of ZMYND8 in primary MM cells than in healthy donor cells (Figure 1E,F). This evidence concerns the gene ZMYND8 and Miyoshi myopathy.